[Clinical and microbiological characteristics of spontaneous bacterial peritonitis (SBP) in a recent five year

Hee Gon Song1, Han Chu Lee, Yeon Ho Joo

  • 1Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea. hch@www.amc.seoul.kr

Abstract

Insights

Antibiotic resistance in spontaneous bacterial peritonitis (SBP) is rising, with increased resistance to cefotaxime and ciprofloxacin observed. This trend necessitates improved infection control and antibiotic stewardship to combat treatment failures.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Clinical Medicine

Context:

  • Spontaneous bacterial peritonitis (SBP) is a serious complication in patients with advanced liver disease.
  • Treatment failure with third-generation cephalosporins in SBP has become increasingly common.
  • Understanding evolving antibiotic resistance patterns is crucial for effective SBP management.

Purpose:

  • To evaluate the changing patterns of antibiotic resistance in microorganisms causing SBP.
  • To assess the clinical significance of increasing antibiotic resistance in SBP.
  • To identify prognostic factors influencing survival in SBP patients.

Summary:

  • A retrospective analysis of 580 SBP episodes (1995-1999) revealed a significant increase in resistance to cefotaxime and ciprofloxacin.
  • Escherichia coli resistance, including extended-spectrum beta-lactamase (ESBL) production, rose substantially.
  • While overall mortality remained stable, factors like renal failure, malignancy, and ESBL-producing organisms impacted survival.

Impact:

  • The study highlights a growing challenge in treating SBP due to antimicrobial resistance.
  • Findings underscore the urgent need for enhanced infection control measures and judicious antibiotic use.
  • This research informs clinical practice and public health strategies for managing SBP in the era of rising resistance.

Related Concept Videos